Comparison of tumor-agnostic and tumor-specific clinical oncology trial designs - supplementary material
收藏DataCite Commons2024-05-16 更新2025-04-15 收录
下载链接：
https://tandf.figshare.com/articles/dataset/Comparison_of_tumor-agnostic_and_tumor-specific_clinical_oncology_trial_designs_-_supplementary_material/23309294
下载链接
链接失效反馈官方服务：
资源简介：
<strong>Supplementary Table 1: Tumor-Specific Trial Search Strategy</strong>
<strong>Supplementary Table 2: Tumor-Agnostic Trial Search Strategy</strong>
<strong>Exhibit 3: Tumor-agnostic trial characteristics</strong>
<strong>Supplementary Table 4: Tumor-agnostic cohort characteristics</strong>
<strong>Supplementary Table 5: Progression-free survival (PFS) and overall survival (OS) estimates from tumor-agnostic trials.</strong>
<strong>Supplementary Table 6: Tumor-specific trial characteristics</strong>
<strong>Supplementary Table 7: Tumor-specific cohort characteristics</strong>
<strong>Supplementary Table 8. Progression-free survival (PFS) and overall survival (OS) estimates from tumor-specific trials. </strong>
<strong>Supplementary Figure 1: Meta-analysis of BRAF inhibitors by trial type.</strong>
<strong>Supplementary Figure 2: Meta-analysis of BRAF/MEK inhibitors by trial type.</strong>
<br>
提供机构：
Taylor & Francis
创建时间：
2023-06-07
